Trials / Recruiting
RecruitingNCT06762873
Assessment of OSA in Latin American and Response to Neuromod Therapy
Assessment of Obstructive Sleep Apnea in the Latin American Population and Response to Neuromodulation Therapy to Treat Obstructive Sleep Apnea
- Status
- Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Lunair Medical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to characterize the upper airway of Latin American subjects who have been diagnosed with moderate/severe obstructive sleep apnea (OSA) and assess response to a neuromodulation therapy to treat OSA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Drug Induced Sleep Endoscopy with PNS | Enrolled subjects will complete an overnight PSG and then undergo a DISE procedure with a 30-minute research period. |
Timeline
- Start date
- 2024-11-21
- Primary completion
- 2024-12-31
- Completion
- 2025-12-31
- First posted
- 2025-01-08
- Last updated
- 2025-09-03
Locations
1 site across 1 country: Paraguay
Source: ClinicalTrials.gov record NCT06762873. Inclusion in this directory is not an endorsement.